Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Apr;15(2):81-6.
doi: 10.4103/0974-9233.51998.

Mitochondrial disorders with significant ophthalmic manifestations

Affiliations

Mitochondrial disorders with significant ophthalmic manifestations

Mona Al-Enezi et al. Middle East Afr J Ophthalmol. 2008 Apr.

Abstract

Mitochondrial diseases are a clinically hetyerogenous group of disorders. They can be caused by mutations of nuclear or mitochondrial DNA (mtDNA). Some affect a single organ, but many involve multiple organ systems and often present with prominent neurologic and myopathic features. The eye is frequently affected, along with muscles and brain, but multisystem disease is common. Ophthalmic manifestations include cataract, retinopathy, optic atrophy, cortical visual loss, ptosis and ophthalmoplegia. Kearns-Sayre Syndrome (KSS), Mitochondrial Encephalopathy, Lactic Acidosis Stroke (MELAS), Myoclonic Epilepsy and Ragged Red Fiber myopathy (MERRF) and Lebers Hereditary Optic Neuropathy (LHON) are well known clinical entities that are secondary to mtDNA abnormalities, which has ophthalmic manifestations. Mitochondrial Dysfunction should be considered in the differential diagnosis of progressive multisystem disorder and specifically if there is associated neuro-ophthalmic manifestations, which may be the presenting symptom of these disorders.

Keywords: Mitochondrial disorder genetics; diagnosis; variable manifestations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Fundus photograph of the left eye showing swollen disc with some telangeictatic vessels (Dr R. Behbehanie patient with permission).
Figure 2
Figure 2
Static perimetry using A: the 24-2 program shows an inferior arcuate defect in the right eye a supranasal and an inferior defect in the left eye; B: 10-2 program shows bilateral central defects.

References

    1. Di Mauro S, Shon EA. Mitochondrial respiratory – chain disease. The New England Journal of Medicine. 2003;348:2656–2668. - PubMed
    1. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neruol Second. 2006;114:217–238. - PubMed
    1. Bionsse Neuro-ophthalmology of mitochondrial diseases. Carr Opin Neural. 2003;16(1):35–43. - PubMed
    1. Chinnery PF. Mitochondrial disorders overview. Gene Review. 2006. Feb, pp. 1–20.
    1. Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. American Journal of Ophthalmology. 2005;140:517–523. - PubMed